Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism

被引:14
作者
Boudou, P
Ibrahim, F
Cormier, C
Sarfati, E
Souberbielle, JC
机构
[1] Hop St Louis, Dept Hormonal Biol, Paris, France
[2] Hop St Louis, Dept Endocrine Surg, Paris, France
[3] Hop Cochin, Dept Rhumatol, F-75674 Paris, France
[4] Hop Necker Enfants Malad, Physiol Lab, Assistance Publ Hop Paris, Paris, France
[5] INSERM, U671, Paris, France
关键词
D O I
10.1373/clinchem.2005.060962
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Third-generation parathyroid hormone (PTH) assays have been reported to measure only intact PTH(1-84), in contrast to second-generation assays, which also detect PTH(7-84) fragments. Higher PTH measurements were observed with third- than with second-generation PTH assays in a few patients with either severe primary hyperparathyroidism or parathyroid carcinoma. Methods: We analyzed biological data [second- and third-generation PTH assays, 25-hydroxyvitamin D (25-OHD), calcium, and phosphate concentrations] obtained before and after surgery for 2 groups of patients selected from a large series of consecutive patients with primary hyperparathyroidism (PHPT): 7 female patients with surgically and histologically confirmed PHPT (group 1) and a matched group (group 2). Results: For group 1 but not group 2, PTH concentrations measured by third-generation PTH assays before surgery were higher than those measured by the second-generation assays. Circulating 25-OHD, calcium, and phosphate concentrations were similar in both groups. In addition, PTH values measured with the third-generation PTH assays in group 1 decreased after-surgery. Conclusions: Our results confirm that third-generation PTH assays do not measure only PTH(1-84). The frequency of this unexpected finding of markedly lower PTH concentrations than previously reported was similar to 5% in patients with PHPT without malignancy. We do not know whether the presence of this unexpected profile is predictive of malignancy. (c) 2006 American Association for Clinical Chemistry.
引用
收藏
页码:757 / 760
页数:4
相关论文
共 12 条
[1]   Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism [J].
Boudou, P ;
Ibrahim, F ;
Cormier, C ;
Chabas, C ;
Sarfati, E ;
Souberbielle, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6370-6372
[2]   Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism [J].
Carnevale, V ;
Dionisi, S ;
Nofroni, I ;
Romagnoli, E ;
Paglia, F ;
De Geronimo, S ;
Pepe, J ;
Clemente, G ;
Tonnarini, G ;
Minisola, S .
CLINICAL CHEMISTRY, 2004, 50 (03) :626-631
[3]   Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism [J].
D'Amour, P ;
Brossard, JH ;
Rousseau, L ;
Roy, L ;
Gao, P ;
Cantor, T .
CLINICAL CHEMISTRY, 2003, 49 (12) :2037-2044
[4]   Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function [J].
Gao, P ;
Scheibel, S ;
D'Amour, P ;
John, MR ;
Rao, SD ;
Schmidt-Gayk, H ;
Cantor, TL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (04) :605-614
[5]   Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone [J].
Inaba, M ;
Nakatsuka, K ;
Imanishi, Y ;
Watanabe, M ;
Mamiya, Y ;
Ishimura, E ;
Nishizawa, Y .
CLINICAL CHEMISTRY, 2004, 50 (02) :385-390
[6]   A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments:: Implications for PTH measurements in renal failure [J].
John, MR ;
Goodman, WG ;
Gao, P ;
Cantor, TL ;
Salusky, IB ;
Jüppner, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4287-4290
[7]  
Koller H, 2004, CLIN NEPHROL, V61, P337
[8]  
Lepage R, 1998, CLIN CHEM, V44, P805
[9]   Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism:: influence of medical treatment and surgery [J].
Räkel, A ;
Brossard, JH ;
Patenaude, JV ;
Albert, C ;
Nassif, E ;
Cantor, T ;
Rousseau, L ;
D'Amour, P .
CLINICAL ENDOCRINOLOGY, 2005, 62 (06) :721-727
[10]   Influence of PTH assay methodology on differential diagnosis of renal bone disease [J].
Reichel, H ;
Esser, A ;
Roth, HJ ;
Schmidt-Gayk, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (04) :759-768